• Kyodo


A medical institution has applied for permission to carry out a clinical trial that will attempt to use embryonic stem cells to treat babies with a severe liver condition, which would be a first for Japan.

The National Center for Child Health and Development plans to commercialize the process around 2020 to treat babies with livers that are unable to detoxify ammonia, one of the compounds resulting from the body’s processing of protein.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.